Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Treatment Effect
100%
Pulmonary Hypertension
100%
Heart Rate Monitoring
100%
Treatment Escalation
100%
Physical Activity
75%
Heart Rate Variability
75%
Pulmonary Arterial Hypertension
75%
Pulmonary Hypertension Treatment
75%
Heart Rate
50%
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
50%
Clinical Outcomes
25%
Early Intervention
25%
Therapeutic Drug Monitoring
25%
Early Treatment
25%
Continuous Monitoring
25%
6-minute Walk Distance (6MWD)
25%
Night-time Heart Rate
25%
Bilateral Lung Transplantation
25%
Loop Recorder
25%
Reveal LINQ
25%
Pulmonary Endarterectomy
25%
Treatment De-escalation
25%
Anti-hypertension Drug
25%
WHO Functional Class
25%
Nighttime Activity
25%
Plain Balloon Angioplasty
25%
Pulmonary Hypertension Therapy
25%
N-terminal pro-B-type Natriuretic Peptide (NT-proBNP)
25%
Heart Rate Activity
25%
Medicine and Dentistry
Treatment Effect
100%
Pulmonary Hypertension
100%
Physical Activity
30%
Heart Rate Variability
30%
Chronic Thromboembolic Pulmonary Hypertension
20%
Prospective Study
10%
Amino Terminal Sequence
10%
Early Intervention
10%
Brain Natriuretic Peptide
10%
Percutaneous Transluminal Angioplasty
10%
Lung Transplantation
10%
Endarterectomy
10%
Walking Distance
10%
Nursing and Health Professions
Pulmonary Hypertension
100%
Heart Rate Variability
30%
Physical Activity
30%
Chronic Thromboembolic Pulmonary Hypertension
20%
Clinical Outcome
10%
Early Intervention
10%
Brain Natriuretic Peptide
10%
Percutaneous Transluminal Angioplasty
10%
Recorder
10%
Lung Transplantation
10%
Endarterectomy
10%
World Health Organization
10%
Walking Distance
10%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
100%
Chronic Thromboembolic Pulmonary Hypertension
20%
Prospective Study
10%
Brain Natriuretic Peptide
10%